Zobrazeno 1 - 10
of 160
pro vyhledávání: '"Gerhart JG"'
Autor:
Carreño FO; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Helfer VE; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Sinha J; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.; Department of Pediatrics, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Kumar KR; Duke Clinical Research Institute, PO Box 17969, Durham, NC, 27715, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Kirkpatrick C; Monash Institute of Pharmaceutical Sciences, Monash University, Victoria, Australia., Hornik CP; Duke Clinical Research Institute, PO Box 17969, Durham, NC, 27715, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Gonzalez D; Duke Clinical Research Institute, PO Box 17969, Durham, NC, 27715, USA. daniel.gonzalez@duke.edu.; Division of Clinical Pharmacology, Department of Medicine, Duke University School of Medicine, Durham, NC, USA. daniel.gonzalez@duke.edu.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2024 Jul; Vol. 63 (7), pp. 999-1014. Date of Electronic Publication: 2024 Jul 02.
Autor:
Salerno SN; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Capparelli EV; Skaggs School of Pharmacy and Pharmaceutical Sciences, University of California San Diego, La Jolla, California, USA., McIlleron H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, South Africa., Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Dumond JB; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Kashuba ADM; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Pharmacotherapy [Pharmacotherapy] 2023 Jul; Vol. 43 (7), pp. 638-649. Date of Electronic Publication: 2022 Jun 08.
Autor:
Ford JL; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Edginton AN; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Yanovski JA; Section on Growth and Obesity, Program in Developmental Endocrinology and Genetics, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, USA., Hon YY; Clinical Pharmacokinetics Research Laboratory, Clinical Center Pharmacy Department, National Institutes of Health, Bethesda, Maryland, USA., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Journal of clinical pharmacology [J Clin Pharmacol] 2022 Aug; Vol. 62 (8), pp. 960-969. Date of Electronic Publication: 2022 Mar 02.
Autor:
Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Carreño FO; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Loop MS; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Lee CR; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Edginton AN; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Sinha J; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Pediatrics, University of North Carolina School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Kumar KR; Duke Clinical Research Institute, Durham, North Carolina, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., Kirkpatrick CM; Centre for Medicine Use and Safety, Monash University, Melbourne, Victoria, Australia., Hornik CP; Duke Clinical Research Institute, Durham, North Carolina, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 Aug; Vol. 112 (2), pp. 391-403. Date of Electronic Publication: 2022 May 18.
Autor:
Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, The University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Carreño FO; Division of Pharmacotherapy and Experimental Therapeutics, The University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Ford JL; Division of Pharmacotherapy and Experimental Therapeutics, The University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Edginton AN; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada., Perrin EM; Department of Pediatrics, School of Medicine and School of Nursing, Johns Hopkins University, Baltimore, Maryland, USA., Watt KM; Division of Pediatric Clinical Pharmacology, School of Medicine, University of Utah, Salt Lake City, Utah, USA., Muller WJ; Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA., Atz AM; Medical University of South Carolina Children's Hospital, Charleston, South Carolina, USA., Al-Uzri A; Oregon Health and Science University, Portland, Oregon, USA., Delmore P; Wesley Medical Center, Wichita, Kansas, USA., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, The University of North Carolina Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2022 Jun; Vol. 11 (6), pp. 778-791. Date of Electronic Publication: 2022 May 02.
Autor:
Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Balevic S; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.; Department of Pediatrics, Duke University Medical Center, Durham, NC, United States.; Duke Clinical Research Institute, Durham, NC, United States., Sinha J; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.; Department of Pediatrics, UNC School of Medicine, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States., Perrin EM; Department of Pediatrics, Johns Hopkins University Schools of Medicine and School of Nursing, Baltimore, MD, United States., Wang J; Office of Drug Evaluation IV, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, United States., Edginton AN; School of Pharmacy, University of Waterloo, Waterloo, ON, Canada., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States.
Publikováno v:
Frontiers in pharmacology [Front Pharmacol] 2022 Mar 10; Vol. 13, pp. 818726. Date of Electronic Publication: 2022 Mar 10 (Print Publication: 2022).
Autor:
Lambrou AS, Shirk P, Steele MK, Paul P, Paden CR, Cadwell B, Reese HE, Aoki Y, Hassell N, Zheng XY, Talarico S, Chen JC, Oberste MS, Batra D, McMullan LK, Halpin AL, Galloway SE, MacCannell DR, Kondor R, Barnes J, MacNeil A, Silk BJ, Dugan VG, Scobie HM, Wentworth DE, Caravas J, Kovacs NA, Gerhart JG, Jia Ng H, Beck A, Chau R, Cintron R, Cook PW, Gulvik CA, Howard D, Jang Y, Knipe K, Lacek KA, Moser KA, Paskey AC, Rambo-Martin BL, Nagilla RR, Retchless AC, Schmerer MW, Seby S, Shepard SS, Stanton RA, Stark TJ, Uehara A, Unoarumhi Y, Bentz ML, Burgin A, Burroughs M, Davis ML, Keller MW, Keong LM, Le SS, Lee JS, Madden Jr JC, Nobles S, Owuor DC, Padilla J, Sheth M, Wilson MM
Publikováno v:
MMWR. Morbidity and mortality weekly report [MMWR Morb Mortal Wkly Rep] 2022 Feb 11; Vol. 71 (6), pp. 206-211. Date of Electronic Publication: 2022 Feb 11.
Autor:
Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA., Carreño FO; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA., Edginton AN; School of Pharmacy, University of Waterloo, Waterloo, ON, Canada., Sinha J; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA., Perrin EM; Department of Pediatrics, School of Medicine and School of Nursing, Johns Hopkins University, Baltimore, MD, USA., Kumar KR; Duke Clinical Research Institute, Durham, NC, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Rikhi A; Duke Clinical Research Institute, Durham, NC, USA., Hornik CP; Duke Clinical Research Institute, Durham, NC, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Harris V; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA., Ganguly S; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA.; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Cohen-Wolkowiez M; Duke Clinical Research Institute, Durham, NC, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA. daniel.gonzalez@unc.edu.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2022 Feb; Vol. 61 (2), pp. 307-320. Date of Electronic Publication: 2021 Oct 07.
Autor:
Ganguly S; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA.; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Edginton AN; School of Pharmacy, University of Waterloo, Kitchener, ON, Canada., Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA., Cohen-Wolkowiez M; Duke Clinical Research Institute, Durham, NC, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Greenberg RG; Duke Clinical Research Institute, Durham, NC, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, NC, USA., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, 301 Pharmacy Lane, Campus Box #7569, Chapel Hill, NC, 27599-7569, USA. daniel.gonzalez@unc.edu.
Publikováno v:
Clinical pharmacokinetics [Clin Pharmacokinet] 2021 Dec; Vol. 60 (12), pp. 1591-1604. Date of Electronic Publication: 2021 Jun 22.
Autor:
Wu YSS; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Cohen-Wolkowiez M; Duke Clinical Research Institute, Durham, North Carolina, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., Hornik CP; Duke Clinical Research Institute, Durham, North Carolina, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, North Carolina, USA., Gerhart JG; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Autmizguine J; Research Center, CHU Sainte-Justine, Montréal, Quebec, Canada.; Department of Pharmacology and Physiology, Université de Montréal, Montreal, Quebec, Canada., Cobbaert M; Duke Clinical Research Institute, Durham, North Carolina, USA., Gonzalez D; Division of Pharmacotherapy and Experimental Therapeutics, UNC Eshelman School of Pharmacy, The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2021 Jun 17; Vol. 65 (7), pp. e0214920. Date of Electronic Publication: 2021 Jun 17.